Revenue declined more than 10% in 2020 vs. 2019, according to ORTHOWORLD's early estimates.The nature of orthopedic conditions meant that not all markets experienced the same revenue drops.
New year, new entrants to the U.S. market. This installation of the recap covers companies based in the U.S., China and Switzerland with Joint Replacement, Spine, Trauma and Sports Medicine devices.
Companies that have exceled at the transition of teams working from home are those that have incorporated and embody, as part of their own internal team culture, the positive benefits of diversity in age, personalities, work preferences and more.
CartiScaff largely resembles original cartilage in terms of structure and composition, and serves as a component of the regenerative tissue, thereby assisting the process or tissue formation.
The BEAR Implant is the first medical technology to clinically demonstrate that it can restore the native ACL without having to replace or reconstruct it.
FDA’s five-point plan outlines the Agency’s thoughts on a tailored regulatory framework, good machine learning practices, patient approaches, technology biases and real world performance.
Supply chain priorities of shorter lead times, higher on-time delivery and greater flexibility are a minefield of obstacles for OEMs and suppliers. We convened a conversation between the two groups to discuss how companies utilize forecasts and ways to gain greater accuracy..
